Market Overview:
The global tuberculosis vaccines market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of tuberculosis, rising demand for effective and affordable vaccines, and growing investments by key players in this market. Based on type, the global tuberculosis vaccines market is segmented into immunotherapeutic vaccines, booster vaccines, and others. Immunotherapeutic vaccines are further sub-segmented into bacille Calmette-Guérin (BCG) vaccine and MVA85A vaccine. Booster vaccines are further sub-segmented into protein purified polysaccharide vaccine (PPPV) and recombinant protein vaccine (RPV). Others include live attenuated mycobacterium vaccae (LAMV), killed mycobacterium vaccae (KMV), adjuvanted BCG vaccine, AS04 adjuvanted PPPV, MPT64/AS01E adjuvanted RPV etc. Private clinics are also expected to witness significant growth during the forecast period owingto rising awareness about vaccination among people residing in developed countries.
Product Definition:
Tuberculosis vaccines are a type of vaccine used to prevent tuberculosis. They are given by injection (either under the skin or into a muscle) or by mouth. The most common tuberculosis vaccine is BCG (bacille Calmette-Guérin).
Immunotherapeutic Vaccines:
An immunotherapeutic vaccine is a type of vaccine that stimulates the immune system to produce antibodies and cellular responses against a particular disease-causing microorganism. The most common diseases for which these vaccines are developed and used are cancer, HIV infection, malaria, dengue fever, hepatitis A & B (Aids), tuberculosis (TB), influenza (flu) and Ebola virus.
Booster Vaccines:
Booster vaccines are used to boost the immune response to a previous dose of a vaccine. They can be used with any type of vaccine, but they are most commonly associated with vaccines for diseases such as measles, polio, and smallpox. The main function of these vaccines is to increase the strength or volume of antibodies that the body produces in response to an infection.
Application Insights:
The hospitals application segment dominated the global market in 2017. The segment is expected to witness significant growth over the forecast period owing to an increase in hospital-acquired immunization records and a rise in demand for immunization against multiple diseases, including chickenpox, typhoid, cholera and measles.
Infectious diseases pose a considerable threat to public health globally; however, vaccination has played an integral role in controlling several infectious diseases such as whooping cough (pertussis), diphtheria & tetanus toxoids & acellular Pertussis vaccine (DTaP), Haemophilus influenzae type b vaccine (Hib) and hepatitis A through hepatitis B vaccines among others. This is projected to fuel product demand over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing awareness about immunization programs, availability of a wide range of products, and high purchasing power. Moreover, government initiatives for funding research activities are also contributing towards growth in this region. For instance, according to an article published by NCBI on April 27th 2018 titled ‘Global Vaccine Market Size & Trends Analysis Report’; U.S.-based foundations invested around USD X billion between 2000 and 2016 supporting vaccine research efforts (NCBI).
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising healthcare expenditure by governments as well as private sectors coupled with growing investments for developing novel therapeutics that can help improve patient care and treatment options (NCBI). In addition, increasing number of clinical trials being conducted in Asian countries will further boost revenue generation opportunities for TB vaccines within this region (NCBI).
Growth Factors:
- Increasing incidence of tuberculosis (TB) across the globe
- Growing awareness about the benefits of TB vaccines
- Rising demand for effective and affordable TB vaccines
- Technological advancements in vaccine development and manufacturing processes
- Government initiatives and funding for TB vaccine research and development
Scope Of The Report
Report Attributes
Report Details
Report Title
TB Vaccines Market Research Report
By Type
Immunotherapeutic Vaccines, Booster Vaccines, Others
By Application
Hospitals, Private Clinics, Research Institutes
By Companies
Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal, Bio Pharma Limited, Statens Serum Institut, Merck & Co.,Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
127
Number of Tables & Figures
89
Customization Available
Yes, the report can be customized as per your need.
Global TB Vaccines Market Report Segments:
The global TB Vaccines market is segmented on the basis of:
Types
Immunotherapeutic Vaccines, Booster Vaccines, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Private Clinics, Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck & Co.,Inc
- Sanofi Pasteur
- Japan BCG Laboratory
- China National Biotec Group
- Serum Institute
- India Pvt. Ltd
- InterVax Ltd
- GreenSignal
- Bio Pharma Limited
- Statens Serum Institut
- Merck & Co.,Inc
Highlights of The TB Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunotherapeutic Vaccines
- Booster Vaccines
- Others
- By Application:
- Hospitals
- Private Clinics
- Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the TB Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
TB vaccines are a series of shots that help protect against tuberculosis (TB). TB is a serious lung infection that can be deadly if not treated. The vaccine helps to prevent TB by protecting people who are most likely to get the disease, such as those who work in close contact with people who have TB, and children under 5 years old.
Some of the key players operating in the tb vaccines market are Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal, Bio Pharma Limited, Statens Serum Institut, Merck & Co.,Inc.
The tb vaccines market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 TB Vaccines Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 TB Vaccines Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 TB Vaccines Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the TB Vaccines Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global TB Vaccines Market Size & Forecast, 2020-2028 4.5.1 TB Vaccines Market Size and Y-o-Y Growth 4.5.2 TB Vaccines Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Immunotherapeutic Vaccines
5.2.2 Booster Vaccines
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Private Clinics
6.2.3 Research Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global TB Vaccines Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 TB Vaccines Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Immunotherapeutic Vaccines
9.6.2 Booster Vaccines
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Private Clinics
9.10.3 Research Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Immunotherapeutic Vaccines
10.6.2 Booster Vaccines
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Private Clinics
10.10.3 Research Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Immunotherapeutic Vaccines
11.6.2 Booster Vaccines
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Private Clinics
11.10.3 Research Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Immunotherapeutic Vaccines
12.6.2 Booster Vaccines
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Private Clinics
12.10.3 Research Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Immunotherapeutic Vaccines
13.6.2 Booster Vaccines
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Private Clinics
13.10.3 Research Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 TB Vaccines Market: Competitive Dashboard
14.2 Global TB Vaccines Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck & Co.,Inc
14.3.2 Sanofi Pasteur
14.3.3 Japan BCG Laboratory
14.3.4 China National Biotec Group
14.3.5 Serum Institute
14.3.6 India Pvt. Ltd
14.3.7 InterVax Ltd
14.3.8 GreenSignal
14.3.9 Bio Pharma Limited
14.3.10 Statens Serum Institut
14.3.11 Merck & Co.,Inc